Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,147 | 67 | 90.5% |
| Education | $61.16 | 3 | 4.8% |
| Gift | $59.40 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dexcom, Inc. | $286.66 | 13 | $0 (2024) |
| Insulet Corporation | $213.06 | 14 | $0 (2020) |
| Shire North American Group Inc | $99.16 | 5 | $0 (2017) |
| Novo Nordisk Inc | $71.23 | 4 | $0 (2024) |
| Valeritas, Inc. | $70.16 | 4 | $0 (2017) |
| Abbott Laboratories | $66.17 | 5 | $0 (2022) |
| Medtronic, Inc. | $64.59 | 3 | $0 (2023) |
| Amgen Inc. | $60.03 | 3 | $0 (2022) |
| MannKind Corporation | $59.40 | 1 | $0 (2018) |
| Aytu BioScience, Inc | $45.67 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.07 | 3 | Dexcom, Inc. ($19.19) |
| 2023 | $112.06 | 5 | Medtronic, Inc. ($51.30) |
| 2022 | $154.04 | 8 | Dexcom, Inc. ($64.34) |
| 2021 | $164.20 | 9 | DEXCOM, INC. ($71.20) |
| 2020 | $52.13 | 3 | Dexcom, Inc. ($19.85) |
| 2019 | $187.12 | 11 | Dexcom, Inc. ($63.60) |
| 2018 | $264.44 | 16 | Insulet Corporation ($92.80) |
| 2017 | $281.24 | 16 | Shire North American Group Inc ($99.16) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Endocrinology | ||||||
| 08/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Endocrinology | ||||||
| 11/02/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Endocrinology | ||||||
| 11/01/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Durable Pump | ||||||
| 06/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Endocrinology | ||||||
| 03/07/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: Durable Pump | ||||||
| 09/22/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 06/10/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 06/08/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Endocrinology | ||||||
| 04/13/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardiology | ||||||
| 04/09/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Endocrinology | ||||||
| 03/15/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes Care | ||||||
| 02/09/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Endocrinology | ||||||
| 01/26/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiology | ||||||
| 12/08/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $35.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/07/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Diabetes Care | ||||||
| 10/18/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes Care | ||||||
| 10/08/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $36.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2021 | VistaPharm, Inc. | Thyquidity (Drug) | Food and Beverage | Cash or cash equivalent | $11.68 | General |
| Category: Hypothyroidism | ||||||
| 09/01/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Diabetes Care | ||||||
| 07/12/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes Care | ||||||
| 07/05/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Neurology | ||||||
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,388 | 7,698 | $431,155 | $164,596 |
| 2022 | 19 | 2,327 | 6,187 | $373,942 | $136,719 |
| 2021 | 24 | 2,622 | 5,982 | $392,815 | $147,753 |
| 2020 | 30 | 2,766 | 5,898 | $379,430 | $125,264 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 50 | 4,380 | $192,720 | $80,859 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 399 | 572 | $79,508 | $33,260 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 233 | $47,998 | $21,048 | 43.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 350 | 589 | $5,301 | $4,901 | 92.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 201 | 265 | $18,815 | $4,289 | 22.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 216 | 346 | $14,186 | $3,261 | 23.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 160 | 213 | $12,141 | $2,772 | 22.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 64 | 89 | $10,235 | $2,582 | 25.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 210 | 275 | $9,900 | $2,265 | 22.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 144 | 170 | $7,650 | $1,751 | 22.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 54 | 116 | $8,120 | $1,320 | 16.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $2,562 | $1,061 | 41.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 32 | 37 | $4,699 | $1,003 | 21.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 19 | 24 | $4,200 | $970.80 | 23.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 90 | 104 | $2,496 | $588.64 | 23.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 47 | 67 | $2,613 | $576.22 | 22.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 92 | 106 | $2,332 | $538.48 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,120 | $494.56 | 44.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 11 | 16 | $1,744 | $404.64 | 23.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 44 | 53 | $1,749 | $403.33 | 23.1% |
| 84146 | Prolactin (milk producing hormone) level | Office | 2023 | 11 | 13 | $1,066 | $246.87 | 23.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 34 | 3,060 | $134,640 | $52,250 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 278 | 407 | $83,842 | $35,960 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 330 | 422 | $58,658 | $24,776 | 42.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 176 | 237 | $16,827 | $3,902 | 23.2% |
About Dr. Paul Moore, MD
Dr. Paul Moore, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114986999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Moore, MD has received a total of $1,267 in payments from pharmaceutical and medical device companies, with $52.07 received in 2024. These payments were reported across 71 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,147).
As a Medicare-enrolled provider, Moore has provided services to 10,103 Medicare beneficiaries, totaling 25,765 services with total Medicare billing of $574,332. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 03/21/2006
- Last Updated 01/28/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1114986999
Products in Payments
- Omnipod (Device) $213.06
- Dexcom G6 Transmitter (Medical Supply) $108.47
- NATPARA (Drug) $99.16
- DEXCOM G6 TRANSMITTER (Device) $71.20
- V-GO (Device) $70.16
- DEXCOM CGM (Device) $63.60
- AFREZZA (Drug) $59.40
- Natesto (Drug) $45.67
- FreeStyle Libre 2 (Device) $45.44
- Repatha (Biological) $43.97
- INVOKANA (Drug) $40.79
- Ozempic (Drug) $34.78
- MINIMED 770G (Device) $33.35
- Korlym (Drug) $32.27
- SOMAVERT (Drug) $27.29
- Dexcom CGM (Device) $23.54
- CYCLOSET (Drug) $21.05
- FREESTYLE LIBRE 2 (Device) $20.73
- DEXCOM G6 CGM SYSTEM (Device) $19.85
- Tresiba (Drug) $19.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Farheen Yousuf, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,161